D019653Chemicals & DrugsD27.505.696.477.656.750D27.505.954.248.58918340.982469Myeloablative Agonistsplugins:FeaturedVideosFeatured Videosplugins:TwitterTwitterprns:emailEncryptedemail addressFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson29844205Harris AC, Boelens JJ, Ahn KW, Fei M, Abraham A, Artz A, Dvorak C, Frangoul H, Freytes C, Gale RP, Hong S, Lazarus HM, Loren A, Mineishi S, Nishihori T, O'Brien T, Williams K, Pasquini MC, Levine JEBlood advancesComparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine. Blood Adv. 2018 06 12; 2(11):1198-1206.Blood Adv2018-06-12T00:00:002018Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine.KoenVan BesienKoen Van Besien0.000000000000000.000000000000002944Van Besien, KoenPROFESSOR1.527370.021111418research area of0.6692750.085952625subject area forMedicine-Hematology and OncologyPediatrics-Hematology and Oncologyhttp://www.uchospitals.edu/physicians/samuel-volchenboum.htmlClinical Pagehttps://voices.uchicago.edu/volchenboum/Sam Volchenboumhttps://ome.bsd.uchicago.eduOffice of Master's Educationhttp://commons.cri.uchicago.eduPediatric Cancer Data Commonshttp://labellelab.uchicago.eduLaBelle LabSamVolchenboumMedicinePediatricsUniversity of ChicagoSusan L.CohnxGFmA69EOfnamXNnYUHhvWD+6g==Susan L. Cohn41.78927490000000-87.601250000000001250Cohn, Susan L.ProfessorSamuel L.VolchenboumxG5/K7QWEeXakH1rLkPq5g==Samuel L. Volchenboum41.78927490000000-87.6012500000000063Volchenboum, Samuel L.Professortrue1PROFESSORPROFESSORtrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor25687795Chen YB, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, Artz A, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson R, Saber W, McCarthy P, Pasquini MCBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationImpact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015 Jun; 21(6):1046-1053.Biol Blood Marrow Transplant2015-02-14T00:00:002015Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.101025840335Holter-Chakrabarty JL, Pierson N, Zhang MJ, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, Cooke KR, Pasquini MC, McCarthy PLBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationThe Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia. Biol Blood Marrow Transplant. 2015 Jul; 21(7):1251-7.Biol Blood Marrow Transplant2015-03-31T00:00:002015The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.27092812Villablanca JG, Volchenboum SL, Cho H, Kang MH, Cohn SL, Anderson CP, Marachelian A, Groshen S, Tsao-Wei D, Matthay KK, Maris JM, Hasenauer CE, Czarnecki S, Lai H, Goodarzian F, Shimada H, Reynolds CPPediatric blood & cancerA Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma. Pediatr Blood Cancer. 2016 08; 63(8):1349-56.Pediatr Blood Cancer2016-04-19T00:00:002016A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.James L.LaBelle3W5oCaQZFemIsW9naE/t8mL1sc65/A==James L. LaBelle0.000000000000000.000000000000002680LaBelle, James L.Associate ProfessorMichael R.BishopMichael R. Bishop0.000000000000000.000000000000002689Bishop, Michael R.Professor27764032Choe HK, Gergis U, Mayer SA, Nagar H, Phillips AA, Shore TB, Smith MJ, van Besien KTransplantationThe Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies. Transplantation. 2017 Jan; 101(1):e34-e38.Transplantation2017-01-01T00:00:002017The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.